pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
ZL-6201
Breast Cancer
$ZLAB
Zai Lab Ltd
0
catalysts
Phase 1
ZM-008
Bile Duct Cancer (Cholangiocarcinoma)
Zumutor Biologics Inc
0
catalysts
Phase 1
ZMAPP
Ebolavirus Infections (Ebola Hemorrhagic Fever)
KBio Inc
0
catalysts
Phase 1
← prev
page 23 of 26
next →
131
Pain
89
Neurology
1
ZW-191
Endometrial Cancer
$ZYME
Zymeworks Inc.
0
catalysts
Phase 1
ZW-251
Hepatocellular Carcinoma
$ZYME
Zymeworks Inc.
0
catalysts
Phase 1
angiotensin II
Muscle Spasm
Type-1 angiotensin II receptor
Platform Therapeutics Inc
0
catalysts
Phase 1
atomoxetine
ATOMOXETINE (atomoxetine [INN])
Attention Deficit Hyperactivity Disorder (ADHD)
Hyloris Pharmaceuticals SA
0
catalysts
Phase 1
azercabtagene zapreleucel
Diffuse Large B-Cell Lymphoma
Imugene Ltd
0
catalysts
Phase 1
basroparib
basroparib [INN]
Colorectal Cancer
ST Pharm Co Ltd
0
catalysts
Phase 1
besufetamig
besufetamig [INN]
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
Ono Pharmaceutical Co Ltd
0
catalysts
Phase 1
calotatug ginistinag
calotatug ginistinag [INN]
Colorectal Cancer
$DAWN
Day One Biopharmaceuticals, Inc.
0
catalysts
Phase 1
cedazuridine + decitabine + tolinapant
cedazuridine + decitabine + tolinapant [INN]
T-Cell Lymphomas
Otsuka Pharmaceutical Co Ltd
0
catalysts
Phase 1
comtifator
Alzheimer's Disease
Bristol-Myers Squibb Co
0
catalysts
Phase 1
crisdesalazine
crisdesalazine [INN]
Amyotrophic Lateral Sclerosis
GNT Pharma Co Ltd
0
catalysts
Phase 1
curcumin
Sickle Cell Disease
Vascarta Inc
0
catalysts
Phase 1
darlifarnib
darlifarnib [INN]
Head And Neck Squamous Cell Carcinoma (HNSC)
$KURA
Kura Oncology, Inc.
0
catalysts
Phase 1
denikitug
Solid Tumor
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 1
deuterated etifoxine
Generalized Anxiety Disorder (GAD)
GABA Therapeutics Inc
0
catalysts
Phase 1
docirbrutinib mesylate
Lymphoma
Carna Biosciences Inc
0
catalysts
Phase 1
dofetilide
Dofetilide (dofetilide)
Atrial Fibrillation
Voltage-gated inwardly rectifying potassium channel KCNH2
Hyloris Pharmaceuticals SA
0
catalysts
Phase 1
eltanolone
eltanolone [INN]
Epilepsy
$LPCN
Lipocine Inc.
0
catalysts
Phase 1
emaretamig
emaretamig [INN]
Adenocarcinoma Of The Gastroesophageal Junction
$XNCR
Xencor Inc
0
catalysts
Phase 1
emiltatug ledadotin
emiltatug ledadotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$DAWN
Day One Biopharmaceuticals, Inc.
0
catalysts
Phase 1
emunkitug
emunkitug [INN]
Cervical Cancer
HiFiBiO Therapeutics Inc
0
catalysts
Phase 1
exarafenib
exarafenib [INN]
Melanoma
Laboratoires Pierre Fabre SA
0
catalysts
Phase 1
exenatide
Byetta (exenatide)
Type 2 Diabetes
$ORMP
ORAMED PHARMACEUTICALS INC.
0
catalysts
Phase 1
faldoritinib
Refractory Acute Myeloid Leukemia
$BMEA
Biomea Fusion, Inc.
0
catalysts
Phase 1
farabursen sodium
Polycystic Kidney Disease
$NVS
NOVARTIS AG
0
catalysts
Phase 1
faridoxorubicin
faridoxorubicin [INN]
Dedifferentiated Liposarcoma
Avacta Life Sciences Ltd
0
catalysts
Phase 1
fb-PMT
Recurrent Glioblastoma Multiforme (GBM)
NanoPharmaceuticals LLC
0
catalysts
